Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments

AIDS Patient Care and STDs
A B HauberJaime E Hernandez

Abstract

While African Americans in the United States are disproportionately affected by HIV, they are less likely to take antiretroviral therapies. Different first-line antiretroviral therapies are associated with short-term and long-term adverse event (AE) risks. We estimated the willingness of antiretroviral-naïve, HIV-positive African Americans to accept risks of acute AEs with known outcomes and long-term AEs with uncertain outcomes in exchange for virologic suppression. We estimated the relative importance of short-term and long-term AE risks. Two hundred thirty-five subjects were recruited through eight clinics in the United States. One hundred fifty-eight subjects met study inclusion criteria. One hundred fifty-three subjects completed a series of choice-format conjoint trade-off tasks. In each task, subjects were asked to choose between two hypothetical treatments with varying levels of virologic failure, risks of hypersensitivity reaction, decreases in bone mineral density (BMD), and renal impairment, and outcome uncertainty associated with the risks of decreased BMD and renal impairment. Attributes were expressed as probabilities of occurrence. We calculated the relative importance of each AE and the level of risk subjects wo...Continue Reading

References

Jun 16, 2000·Journal of the National Cancer Institute. Monographs·I M Lipkus, J G Hollands
Mar 9, 2004·British Journal of Anaesthesia·T J GanC Chen
Nov 13, 2004·The Annals of Pharmacotherapy·Amy G CutrellTrevor R Scott
Aug 11, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Kathleen M BeusterienJamie C Jordan
Oct 2, 2007·Journal of Women's Health·F Reed JohnsonTeresa L Kauf
Feb 8, 2008·The New England Journal of Medicine·Simon MallalUNKNOWN PREDICT-1 Study Team
Apr 22, 2008·AIDS Patient Care and STDs·Maria Paola TrottaUNKNOWN AdICoNA and AdeSpall Study Group

❮ Previous
Next ❯

Citations

Jul 28, 2011·Patient Preference and Adherence·A Brett HauberNorman Scherzer
Jan 26, 2012·The Patient·Ateesha F MohamedCheryl D Coon
Aug 23, 2011·PharmacoEconomics·Ateesha F MohamedMaureen P Neary
May 3, 2013·Applied Health Economics and Health Policy·A Brett HauberF Reed Johnson
Feb 15, 2012·European Journal of Gastroenterology & Hepatology·Ateesha Farah MohamedAllan Masterson
Aug 1, 2012·Journal of Medical Economics·Ateesha F MohamedJosephine M Li-McLeod
Dec 17, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Vikram KilambiAteesha F Mohamed
Nov 13, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·A F MohamedJ M Li-McLeod
Jun 29, 2010·Journal of Viral Hepatitis·A Brett HauberJ Mauskopf
Mar 20, 2016·Applied Health Economics and Health Policy·Axel Mühlbacher, F Reed Johnson
Apr 24, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeff J GuoDennis W Raisch
Oct 31, 2019·PloS One·John M HumphreyGregory D Zimet
Feb 27, 2020·Journal of Medical Economics·Eric SijstermansMickael Hiligsmann
Feb 27, 2020·Journal of Medical Economics·Anne J M GoossensMickael Hiligsmann
Nov 11, 2016·PharmacoEconomics·Henk BroekhuizenCatharina G M Groothuis-Oudshoorn
Apr 17, 2020·Current HIV/AIDS Reports·José A BauermeisterDouglas S Krakower
Aug 9, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jan OstermannNathan M Thielman
Sep 1, 2021·Cost Effectiveness and Resource Allocation : C/E·Yihalem Abebe BelayFitalew Agimass Taye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.